Therefore, in the current study, we tested the hypothesis that the addition of ACE inhibition to exogenous Ang 1–7 may unmask beneficial cardiac effects of Ang 1–7 in kidney disease. The gene discussed is ANGPT1; the disease is kidney disorder.